{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:09:37Z","timestamp":1777954177915,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.bbrc.2014.04.021","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T07:30:55Z","timestamp":1397374255000},"page":"550-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection"],"prefix":"10.1016","volume":"447","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.04.021_b0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1743-422X-10-250","article-title":"Establishment of cell lines with increased susceptibility to EV71\/CA16 by stable overexpression of SCARB2","volume":"10","author":"Li","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.bbrc.2014.04.021_b0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of Enterovirus 71 infection in Taiwan","volume":"341","author":"Ho","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2014.04.021_b0015","doi-asserted-by":"crossref","first-page":"e1001174","DOI":"10.1371\/journal.ppat.1001174","article-title":"Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection","volume":"6","author":"Nishimura","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2014.04.021_b0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12250-012-3245-x","article-title":"Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells","volume":"27","author":"Jin","year":"2012","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bbrc.2014.04.021_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2014.04.021_b0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1386-6532(01)00214-1","article-title":"Echovirus 7 associated encephalomyelitis","volume":"23","author":"Lum","year":"2002","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-inactivated whole-virus vaccine protects a murine model of Enterovirus 71 encephalomyelitis against disease","volume":"84","author":"Ong","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type I and type II interferon mediated signaling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type I interferons and the virus\u2013host relationship: a lesson in d\u00e9tente","volume":"312","author":"Garc\u00eda-Sastre","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2014.04.021_b0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Virus and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Ann. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0055","doi-asserted-by":"crossref","first-page":"e1000196","DOI":"10.1371\/journal.ppat.1000196","article-title":"Influenza A virus inhibits type I IFN signaling via NF-kB dependent induction of SOCS-3 expression","volume":"4","author":"Pauli","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2014.04.021_b0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.20854","article-title":"Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines","volume":"42","author":"Zhang","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.04.021_b0065","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1128\/JVI.79.9.5414-5420.2005","article-title":"Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression","volume":"79","author":"Jones","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0070","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1128\/JVI.79.14.9315-9319.2005","article-title":"Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of stat2 expression and alpha\/beta interferon responsiveness","volume":"79","author":"Mindy","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0075","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1128\/JVI.00447-11","article-title":"Cleavage of the adaptor protein TRIF by Enterovirus 71 3C inhibits antiviral responses mediated by Toll-Like Receptor 3","volume":"85","author":"Lei","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0080","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1128\/JVI.06687-11","article-title":"Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1","volume":"86","author":"Lu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0085","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1128\/JVI.02491-09","article-title":"The 3C protein of Enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses","volume":"84","author":"Lei","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbrc.2008.04.006","article-title":"Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells","volume":"371","author":"Yohichi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.04.021_b0095","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1099\/0022-1317-83-6-1367","article-title":"Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death","volume":"83","author":"Kuo","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0100","doi-asserted-by":"crossref","first-page":"e63431","DOI":"10.1371\/journal.pone.0063431","article-title":"MDA5 plays a crucial role in Enterovirus 71 RNA mediated IRF3 activation","volume":"8","author":"Kuo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.04.021_b0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/CMR.00048-08","article-title":"HLA and infectious diseases","volume":"22","author":"Blackwell","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2014.04.021_b0110","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1128\/JVI.05633-11","article-title":"ISG56 and IFITM1 proteins inhibit hepatitis C virus replication","volume":"85","author":"Raychoudhuri","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.021_b0115","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.23509","article-title":"DITTO-HCV and NORDynamIC Study Groups. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C","volume":"51","author":"Askarieh","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.04.021_b0120","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.1074\/jbc.M707697200","article-title":"Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.021_b0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/FBP.0b013e32833d41b2","article-title":"Using glutamate homeostasis as a target for treating addictive disorders","volume":"21","author":"Reissner","year":"2010","journal-title":"Behav. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14006524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14006524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T20:51:17Z","timestamp":1538686277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14006524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0006291X14006524"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.021","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}